Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+18.9%
5Y CAGR+34.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+18.9%/yr
vs +29.6%/yr prior
5Y CAGR
+34.3%/yr
Recent deceleration
Acceleration
-10.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.4x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $598.92M | +17.1% |
| 2024 | $511.60M | +32.1% |
| 2023 | $387.25M | +8.7% |
| 2022 | $356.23M | +32.3% |
| 2021 | $269.30M | +96.6% |
| 2020 | $136.95M | +1.4% |
| 2019 | $135.12M | +7.2% |
| 2018 | $126.08M | +1.3% |
| 2017 | $124.44M | +7.8% |
| 2016 | $115.40M | - |